SVM UK OPPORTUNITIES - Manager
No Bestinvest rating
Find rated uk all companies funds
Average monthly relative returns
|
Bestinvest MRI
|
|
07/08
|
08/09
|
09/10
|
10/11
|
11/12
|
|
3 years
|
5 years
|
Career
|
3 years
|
5 years
|
Career
|
|
-0.67%
|
-0.99%
|
1.94%
|
0.49%
|
-0.20%
|
|
0.74%
|
0.11%
|
0.13%
|
91.2%
|
65.2%
|
69.5%
|
|
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
|
Neil Veitch
Prior to joining SVM, Veitch was responsible for UK mid & small cap investments at Dutch merchant bank, Kempen Capital Management. As well as managing the UK portfolios, he also managed European mandates. He holds a BA (Hons) in Economics, a MSc in Investment Management and is qualified as a Chartered Financial Analyst (CFA). His sector responsibilities include European industrials, technology, oil and gas E&P and UK support services & house builders.
Track record
Neil Veitch has 6.3 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.13%.
During the worst period of relative performance (from April 2006 - October 2008) there was a decline of 44% relative to the index. The worst absolute loss has been 66%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 70%.
Other funds managed
| Periods of worst performance |
|
Absolute
|
-66%
(May 2007 - February 2009)
|
|
Relative
|
-44%
(April 2006 - October 2008)
|
Sector record since
January 2006 (6 yrs)
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level. Read more about our approach